Aquestive Therapeutics CEO Daniel Barber disposes of 25,000 common shares worth $107,168
Reuters2026/08/18 20:13Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on Aug. 17, 2026.
- Sale priced at a weighted average of $4.29 per share.
- Post-transaction holding reported at 585,574 shares.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aquestive Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001214659-26-010516), on August 18, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
FRP Holdings Director John D. Baker II reports purchase of USD 201,009 in common shares
Reuters•2026/08/18 21:39
Conduent files Form 3 for EVP, GC and Secretary Anna Rose Novoseletsky
Reuters•2026/08/18 21:35
EQB publishes abridged supplementary financial information package ahead of Q3 2026 results
Reuters•2026/08/18 21:35
Parlem Telecom renews Banco Sabadell credit line at EUR 1 million
Reuters•2026/08/18 21:35
